F.R.S.-FNRS (Fonds de la Recherche Scientifique)
EP PerMed JTC 2027 – Cell and Gene Therapy for Personalised Medicine (CGT4PM2027)
Last seen in a scan/import: .
Catalog updated: .
These timestamps are not source verification. Confirm the current deadline and your eligibility on the funder’s call page before applying.
The EP PerMed JTC 2027 call on Cell and Gene Therapy for Personalised Medicine (CGT4PM2027) funds research projects in this field through F.R.S.-FNRS, Belgium's French-speaking community research agency. It is open to researchers based at a French-Community university or approved research centre in Belgium, typically as part of a transnational consortium under the EP PerMed joint call framework.
Details
| Funder | F.R.S.-FNRS (Fonds de la Recherche Scientifique) |
| Deadline | 27 January 2027 |
| Eligible countries | BE |
Eligibility & scope
EP PerMed JTC 2027 – Cell and Gene Therapy for Personalised Medicine (CGT4PM2027) from the F.R.S.-FNRS, the research-funding agency for Belgium's French-speaking community (Wallonia–Brussels). The host institution must be a French-Community university or approved research centre in Belgium.
Who Should Apply
- •Researchers hosted at a French-Community university or approved research centre in Belgium
- •Teams working on cell and gene therapy approaches to personalised medicine
- •Applicants able to join or lead a transnational consortium under the EP PerMed joint call
- •Belgian partners in international cell and gene therapy research collaborations
Key Dates
- •Deadline: 27 January 2027
- •Part of the EP PerMed JTC 2027 joint transnational call
Tips for Applicants
- ✓Confirm host-institution eligibility with F.R.S.-FNRS before assembling a consortium, since only French-Community institutions in Belgium qualify for this national funding stream.
- ✓As a joint transnational call, coordinate early with international partners on the shared EP PerMed submission requirements alongside the FNRS national application.
- ✓Check the FNRS website for the specific national annex requirements that accompany the transnational proposal.
Frequently Asked Questions
Who can apply to the EP PerMed JTC 2027 CGT4PM2027 call?
Researchers based at a French-Community university or approved research centre in Belgium (Wallonia, Brussels).
What is the deadline for EP PerMed JTC 2027 CGT4PM2027?
The deadline is 27 January 2027.
Which funder administers the Belgian part of this call?
F.R.S.-FNRS, the research-funding agency for Belgium's French-speaking community.
What research topic does CGT4PM2027 cover?
Cell and gene therapy for personalised medicine, as part of the EP PerMed joint transnational call programme.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
Cell and Gene Therapy for Personalised Medicine
Research Council of NorwayDeadline: 20 Jan 2027WEL-T Investigator Programme 2026
F.R.S.-FNRS (Fonds de la Recherche Scientifique)Deadline: 5 Nov 2026SofinaBoël Fellowships 2027
F.R.S.-FNRS (Fonds de la Recherche Scientifique)Deadline: 26 Oct 2026ERA4Health JTC 2027 – Nano and advanced technologies for developing Diagnostic tools to improve the detection and the clinical management of noncommunicable diseases (NanoDiagNCD)
F.R.S.-FNRS (Fonds de la Recherche Scientifique)Deadline: 26 Jan 2027Amorçage de jeunes équipes 2026 - Session 3
Fondation pour la Recherche Médicale (FRM)Deadline: 6 Nov 2026
Browse Related
Could EP PerMed JTC 2027 – Cell and Gene Therapy for Personalised Medicine (CGT4PM2027) be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →